Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
LCTXLineage Cell Therapeutics	$230.64m	n/a	n/a
CDXSCodexis	$229.48m	n/a	n/a
TVGNTevogen Bio Holdings	$228.71m	n/a	n/a
SLRNAcelyrin	$227.15m	n/a	n/a
SLNCFSilence Therapeutics	$226.71m	n/a	n/a
MACKMerrimack Pharmaceuticals	$223.75m	n/a	n/a
MNPRMonopar Therapeutics	$221.68m	n/a	n/a
SLSSellas Life Sciences	$216.52m	n/a	n/a
EDITEditas Medicine	$215.14m	n/a	n/a
DSGNDesign Therapeutics	$214.02m	n/a	n/a
SPPISpectrum Pharmaceuticals	$211.40m	n/a	n/a
TVRDTvardi Therapeutics	$210.25m	n/a	n/a
KODKodiak Sciences	$208.42m	n/a	n/a
ACIUAC Immune SA	$207.85m	n/a	n/a
METXME Therapeutics Holdings	CA$281.10m	n/a	n/a
CRGXCARGO Therapeutics	$205.67m	n/a	n/a
LRMRLarimar Therapeutics	$204.89m	n/a	n/a
FDMT4D Molecular Therapeutics	$196.42m	n/a	n/a
EPRXEupraxia Pharmaceuticals	CA$265.72m	n/a	n/a
ENGNenGene Holdings	$194.20m	n/a	n/a